Dirk Syburra - Medical Marijuana VP Technology
| MJNA Stock | USD 0.0006 0.0001 14.29% |
Insider
Dirk Syburra is VP Technology of Medical Marijuana I
| Phone | 866 273 8502 |
| Web | https://www.medicalmarijuanainc.com |
Medical Marijuana Management Efficiency
The company has return on total asset (ROA) of (0.0146) % which means that it has lost $0.0146 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1206 %, meaning that it created $0.1206 on every $100 dollars invested by stockholders. Medical Marijuana's management efficiency ratios could be used to measure how well Medical Marijuana manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 9 records | INSIDER Age | ||
| Zohar Krivorot | Cannara Biotech | 46 | |
| Alexander Wolfe | Cannara Biotech | N/A | |
| Avi Krivorot | Cannara Biotech | N/A | |
| Brian Sherman | Cannara Biotech | N/A | |
| France Landry | Cannara Biotech | N/A | |
| Anthony Manouk | Cannara Biotech | N/A | |
| Etienne Ledoux | Cannara Biotech | N/A | |
| David Abitbol | Cannara Biotech | N/A | |
| Julia Bouvet | Cannara Biotech | N/A | |
Management Performance
| Return On Equity | 0.12 | |||
| Return On Asset | -0.0146 |
Medical Marijuana Leadership Team
Elected by the shareholders, the Medical Marijuana's board of directors comprises two types of representatives: Medical Marijuana inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medical. The board's role is to monitor Medical Marijuana's management team and ensure that shareholders' interests are well served. Medical Marijuana's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medical Marijuana's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Blake Esq, Chairman CEO | ||
| Tyler Whatcott, Chief Officer | ||
| Rubens Wajnsztejn, Chief Officer | ||
| Michelle Esq, Chief Director | ||
| DDS MD, Member Biotechnologies | ||
| Dirk Syburra, VP Technology | ||
| Chuck Smith, Chief Holdings | ||
| Todd Morrow, President |
Medical Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Medical Marijuana a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.12 | |||
| Return On Asset | -0.0146 | |||
| Profit Margin | 0.15 % | |||
| Operating Margin | (0.04) % | |||
| Current Valuation | 62.53 M | |||
| Shares Outstanding | 3.44 B | |||
| Price To Earning | 5.25 X | |||
| Price To Book | 0.55 X | |||
| Price To Sales | 0.86 X | |||
| Revenue | 58.98 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Medical Pink Sheet
Medical Marijuana financial ratios help investors to determine whether Medical Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medical with respect to the benefits of owning Medical Marijuana security.